Navigation Links
VA Announces SGLI and VGLI Premium Reductions
Date:4/7/2008

Peake: Change Makes Programs More Affordable

WASHINGTON, April 7, 2008 /PRNewswire-USNewswire/ -- Veterans and military personnel with life insurance policies managed by the Department of Veterans Affairs (VA) will see a reduction in their premiums, thanks to improved investment earnings and a reduction in non-combat claims.

The premium cuts affect military personnel covered by Servicemembers' Group Life Insurance (SGLI) and veterans covered by the Veterans' Group Life Insurance (VGLI).

"The reduction in SGLI premiums makes life insurance even more affordable for today's men and women in uniform," said Secretary of Veterans Affairs Dr. James B. Peake. "Lower VGLI premiums will allow more veterans to provide this low-cost financial security to their families."

On July 1, 2008, the premiums for basic SGLI will be 6.5 cents per month for $1,000 of coverage, down from 7 cents per month for $1,000. This translates into a 7 percent savings.

Servicemembers with the maximum $400,000 of coverage will see their monthly premium reduced from $28 to $26. Servicemembers are also covered against severe traumatic injury for an additional dollar each month.

The reduction in SGLI premiums is made possible by lower, non-combat-related claims and increases in investment earnings. VA officials believe this premium reduction will help maintain the nearly universal participation in the program.

VGLI provides renewable term policies for people after their discharges from the military. Veterans pay premiums according to their age for this coverage.

On July 1, 2008, VGLI premium rates will be reduced for veterans aged 30 to 64, who make up 85 percent of those insured under the program. Premium rates for those under age 30 are already competitive.

Premium reductions, ranging from 4 percent to 12 percent, are a result of fewer claims being received. The reductions will ensure that VGLI remains highly compet
'/>"/>

SOURCE U.S. Department of Veterans Affairs
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. HHS Announces $75 Million in Supplemental Funding to States for Pandemic Flu Preparedness
2. CRC Health Group Announces Acquisition of Bayside Marin Recovery Center, San Rafael
3. UHW Announces: Antelope Valley Hospital Caregivers and Board Vote to Ratify First Union Contract With SEIU UHW-West
4. HEI, Inc. Announces Sale of RFID Division Assets
5. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Zyloprim(R)
6. Mettler-Toledo International Inc. Announces Webcast of Presentation at Thomas Weisel Partners 2007 Healthcare Conference
7. Z Trim Announces Revocation of Gregory Halpern Severence Agreement
8. Brooke Franchise Corporation Announces Selected July Results
9. Manor Care, Inc. Announces Record Date for Special Stockholder Meeting
10. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Adipex-P(R)
11. Planet Technologies Announces Agreement to Acquire Antigen Laboratories
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/21/2008)...HASSEE, Fla. -- A Florida State University College...s discovered an important new layer of regulation ...greater understanding of the way cancer begins. ,...ces at the College of Medicine, said the findings ...r and could lead to the design of new drugs that k...
(Date:11/21/2008)..., Va., Nov. 21 The Gene...e following statement today from,GPhA President a... Commission,(FTC) roundtable on "Emerging Health ...he mere fact that the FTC is conducting this round...suring that consumers have access to safe and,aff...
(Date:11/21/2008)...N, W.Va., Nov. 21 New r... whether a smokeless, spitless tobacco product aim...hers have found that RJ Reynolds, Camel Snus - tou...ion - contains surprisingly high levels of nicotin...han most other snuff products," said Bruce Adkins ...
(Date:11/21/2008)...LAKES, N.J., Nov. 21 Tod...dical intervention in treating 88 percent of patie...of Americans treated for a chronic condition accou...g and 75 percent of all medical costs. A propriet...by Medco Health Solutions, Inc. (NYSE: MHS ) sig...
Breaking Medicine News(10 mins):Health News:GPhA Statement on FTC Roundtable on Biogenerics 2Health News:Experts Say New Tobacco Product Targets Young Adults 2Health News:Experts Say New Tobacco Product Targets Young Adults 3Health News:New Data: Advanced Pharmacy Model Significantly Reduces Gaps in Care for Patients with Chronic and Complex Conditions; Improves Clinical and Financial Outcomes 2Health News:New Data: Advanced Pharmacy Model Significantly Reduces Gaps in Care for Patients with Chronic and Complex Conditions; Improves Clinical and Financial Outcomes 3Health News:New Data: Advanced Pharmacy Model Significantly Reduces Gaps in Care for Patients with Chronic and Complex Conditions; Improves Clinical and Financial Outcomes 4Health News:New Data: Advanced Pharmacy Model Significantly Reduces Gaps in Care for Patients with Chronic and Complex Conditions; Improves Clinical and Financial Outcomes 5Health News:New Data: Advanced Pharmacy Model Significantly Reduces Gaps in Care for Patients with Chronic and Complex Conditions; Improves Clinical and Financial Outcomes 6
...isk increase by gene variant A group of research ...omanian colleagues has discovered a gene variant w...one considerably (Hepatology No. 46, 11 July 2007,...e on ten Europeans has this variant in their genet...
...ty prevalence increased from 13 percent to 32 perc...rchers at the Johns Hopkins Bloomberg School of Pu...lence of obesity and overweight has increased at a...nts across different sociodemographic groups over ...
...selective of its reaction to a particular variety ...i . According to Biology textbooks neutrophils are...WBC) form an integral part of blood. They are the ...y. They protect our body from various kinds of inf...
... Dana-Farber Cancer Institute have identified a lo...on of brown fat , a type of adipose tissue that ge...ting. A team headed by Bruce Spiegelman, PhD, sug...ism that turning up the equivalent switch in peopl...
Other Medicine News:Health News:Gallstone Gene Discovered by Research Team 2Health News:U.S Shows Increased Obesity Rate 2Health News:WBC Selective About Sugar 2Health News:Scientists Identified Obesity Control Switch 2
(Date:11/20/2008)..., Nov. 20 PAREXEL Intern...lobal biopharmaceutical services provider, today a...u to provide regulatory consulting and clinical re... office, PAREXEL now has locations throughout five...ica, which also include Argentina, Brazil, Chile, ...
(Date:11/19/2008)...ND OAKS, Calif., Nov. 19 ...da Oncology Company, a subsidiary of,Takeda Pharm...nced that,enrollment in the Phase 3 MONET1 trial ...h paclitaxel and carboplatin for the first-line tr...SCLC) has been temporarily suspended,following a ...
(Date:11/19/2008)...CHELLE, N.Y., Nov. 19 Biotech scie...gies to toxicology research to better understand t...f organ systems, reports Genetic Engineering &... interested in figuring out a new compound,s mecha...ive toxicology technique, according to the Novembe...
(Date:11/18/2008)..., November 19 NeuroDisco...vice provider and drug development Company,and S...: 4565), a leading,international biopharmaceutica...presenting further pivotal pre-clinical efficacy d...is a potential therapy for neuropathic pain and ha...
Breaking Medicine Technology:PAREXEL Strengthens Leading Presence in Latin America With a New Location in Peru 2PAREXEL Strengthens Leading Presence in Latin America With a New Location in Peru 3PAREXEL Strengthens Leading Presence in Latin America With a New Location in Peru 4Amgen, Takeda and Millennium Provide Update on Phase 3 Trial of Motesanib in Patients With Non-Small Cell Lung Cancer 2Amgen, Takeda and Millennium Provide Update on Phase 3 Trial of Motesanib in Patients With Non-Small Cell Lung Cancer 3Amgen, Takeda and Millennium Provide Update on Phase 3 Trial of Motesanib in Patients With Non-Small Cell Lung Cancer 4Amgen, Takeda and Millennium Provide Update on Phase 3 Trial of Motesanib in Patients With Non-Small Cell Lung Cancer 5Amgen, Takeda and Millennium Provide Update on Phase 3 Trial of Motesanib in Patients With Non-Small Cell Lung Cancer 6Amgen, Takeda and Millennium Provide Update on Phase 3 Trial of Motesanib in Patients With Non-Small Cell Lung Cancer 7GEN Reports on the Trend Toward Predictive Toxicogenomics 2Sosei and NeuroSolutions Present Further Data on NSL-043/SD118 at the Society for Neuroscience 38th Annual Meeting 2Sosei and NeuroSolutions Present Further Data on NSL-043/SD118 at the Society for Neuroscience 38th Annual Meeting 3Saving the wild orchids of Borneo 4093 1Saving the wild orchids of Borneo 4093 2Genetic variant increases triglyceride levels in Asian Americans 4091 1Genetic variant increases triglyceride levels in Asian Americans 4091 2Researchers discover a gene that regulates and blocks ovulation 4089 1gloEMR Version 4 0 gloStream 26apos 3Bs Flagship Electronic Medical Record Solution Receives 2007 CCHIT Certification 24163 1gloEMR Version 4 0 gloStream 26apos 3Bs Flagship Electronic Medical Record Solution Receives 2007 CCHIT Certification 24163 2gloEMR Version 4 0 gloStream 26apos 3Bs Flagship Electronic Medical Record Solution Receives 2007 CCHIT Certification 24163 3
...dia 4000 is a hospital-grade Holter Monitoring Sys...Diogenes Arrhythmia and ST analysis algorithm, Hea...rdware and software. Facilities with an Epicardia ... reports, customizing them to suit their needs, an...
An aid for advancing a pacemaker lead through the subcutaneous tissue of the chest wall to the pacemaker pocket.
...at™ System is the first thrombectomy catheter...licity for the full range of thrombus removal proc... the new ThromCat™ System flushes, macerates,...nd incorporates advanced vessel-wall safety featur...
LifeStent FlexStar delivery systems offer clinicians multiple methods for stent deployment to accommodate individual preference.
Medicine Products: